These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 16149090

  • 1. Long-term results of hyperfractionated radiation and high-dose intraarterial cisplatin for unresectable oropharyngeal carcinoma.
    Spring PM, Valentino J, Arnold SM, Sloan D, Kenady D, Kudrimoti M, Haydon RC, Lee C, Given C, Mohiuddin M, Regine WF.
    Cancer; 2005 Oct 15; 104(8):1765-71. PubMed ID: 16149090
    [Abstract] [Full Text] [Related]

  • 2. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T, Becker A, Pigorsch S, Pelz T, Bloching M, Passmann M, Lotterer E, Hänsgen G, Dunst J.
    Strahlenther Onkol; 2003 Oct 15; 179(10):673-81. PubMed ID: 14566475
    [Abstract] [Full Text] [Related]

  • 3. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V, Parsons JT, Greene BD, Sharma V.
    Head Neck; 2009 Feb 15; 31(2):167-74. PubMed ID: 18853443
    [Abstract] [Full Text] [Related]

  • 4. A pilot study of high-dose intraarterial cisplatin chemotherapy with concomitant accelerated radiotherapy for patients with previously untreated T4 and selected patients with T3N0-N3M0 squamous cell carcinoma of the upper aerodigestive tract.
    Foote RL, Kasperbauer JL, Okuno SH, Nichols DA, Olsen KD, Brown PD, Garces YI, Sargent DJ, Strome SE.
    Cancer; 2005 Feb 01; 103(3):559-68. PubMed ID: 15597408
    [Abstract] [Full Text] [Related]

  • 5. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, Wacha J, Bayouth JE, Funk GF, Smith RB, Graham SM, Chang K, Hoffman HT.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):410-21. PubMed ID: 16168834
    [Abstract] [Full Text] [Related]

  • 6. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615.
    Robbins KT, Kumar P, Harris J, McCulloch T, Cmelak A, Sofferman R, Levine P, Weisman R, Wilson W, Weymuller E, Fu K.
    J Clin Oncol; 2005 Mar 01; 23(7):1447-54. PubMed ID: 15735120
    [Abstract] [Full Text] [Related]

  • 7. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
    Zamboglou N, Pape H, Schnabel T, Wurm R, Bannach B, Fürst G, Schmitt G.
    Strahlenther Onkol; 1989 Sep 01; 165(9):647-51. PubMed ID: 2678546
    [Abstract] [Full Text] [Related]

  • 8. High-dose intra-arterial cisplatin therapy followed by radiation therapy for advanced squamous cell carcinoma of the head and neck.
    Wilson WR, Siegel RS, Harisiadis LA, Davis DO, Nguyen HH, Bank WO.
    Arch Otolaryngol Head Neck Surg; 2001 Jul 01; 127(7):809-12. PubMed ID: 11448355
    [Abstract] [Full Text] [Related]

  • 9. Results of phase I-II trial of concomitant hyperfractionated radiation and oral etoposide (VP-16) in patients with unresectable squamous cell carcinoma of the head and neck.
    Khafif A, Canfield VA, Syzek EJ, Medina JE.
    Am J Otolaryngol; 2003 Jul 01; 24(1):1-5. PubMed ID: 12579475
    [Abstract] [Full Text] [Related]

  • 10. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
    de Arruda FF, Puri DR, Zhung J, Narayana A, Wolden S, Hunt M, Stambuk H, Pfister D, Kraus D, Shaha A, Shah J, Lee NY.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):363-73. PubMed ID: 15925451
    [Abstract] [Full Text] [Related]

  • 11. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
    Stadler P, Putnik K, Kreimeyer T, Sprague LD, Koelbl O, Schäfer C.
    BMC Cancer; 2006 Dec 07; 6():279. PubMed ID: 17150114
    [Abstract] [Full Text] [Related]

  • 12. High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer.
    Balm AJ, Rasch CR, Schornagel JH, Hilgers FJ, Keus RB, Schultze-Kool L, Ackerstaff AH, Busschers W, Tan IB.
    Head Neck; 2004 Jun 07; 26(6):485-93. PubMed ID: 15162349
    [Abstract] [Full Text] [Related]

  • 13. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.
    Huguenin P, Beer KT, Allal A, Rufibach K, Friedli C, Davis JB, Pestalozzi B, Schmid S, Thöni A, Ozsahin M, Bernier J, Töpfer M, Kann R, Meier UR, Thum P, Bieri S, Notter M, Lombriser N, Glanzmann C.
    J Clin Oncol; 2004 Dec 01; 22(23):4665-73. PubMed ID: 15534360
    [Abstract] [Full Text] [Related]

  • 14. Rapid superselective high-dose cisplatin infusion with concomitant radiotherapy for advanced head and neck cancer.
    Homma A, Furuta Y, Suzuki F, Oridate N, Hatakeyama H, Nagahashi T, Ushikoshi S, Asano T, Nishioka T, Shirato H, Fukuda S.
    Head Neck; 2005 Jan 01; 27(1):65-71. PubMed ID: 15459915
    [Abstract] [Full Text] [Related]

  • 15. Radiotherapy and concomitant intraarterial cisplatin (RADPLAT) for advanced squamous cell carcinomas of the head and neck.
    Rabbani A, Hinerman RW, Schmalfuss IM, Amdur RJ, Morris CG, Peters KR, Robbins KT, Mendenhall WM.
    Am J Clin Oncol; 2007 Jun 01; 30(3):283-6. PubMed ID: 17551306
    [Abstract] [Full Text] [Related]

  • 16. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911.
    Langer CJ, Harris J, Horwitz EM, Nicolaou N, Kies M, Curran W, Wong S, Ang K.
    J Clin Oncol; 2007 Oct 20; 25(30):4800-5. PubMed ID: 17947728
    [Abstract] [Full Text] [Related]

  • 17. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).
    Bensadoun RJ, Bénézery K, Dassonville O, Magné N, Poissonnet G, Ramaïoli A, Lemanski C, Bourdin S, Tortochaux J, Peyrade F, Marcy PY, Chamorey E, Vallicioni J, Seng H, Alzieu C, Géry B, Chauvel P, Schneider M, Santini J, Demard F, Calais G.
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):983-94. PubMed ID: 16376489
    [Abstract] [Full Text] [Related]

  • 18. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P, Valavaara R, Aitasalo K, Kulmala J, Laine J, Elomaa L, Sillanmäki L, Minn H, Grénman R.
    Radiother Oncol; 2006 Feb 15; 78(2):146-51. PubMed ID: 16307813
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.